Literature DB >> 2478460

An epitope on C4 beta light (L) chains detected by human anti-Rg; its relationship with beta chain polymorphism and MHC associations.

T Robson1, R N Heard, C M Giles.   

Abstract

Two out of ten Rg-specific antisera tested contain a third antibody specific for the beta chain of C4. Analysis of the beta chains of 66 unrelated individuals by sodium dodecyl sulfate polyacrylamide gel electrophoresis revealed that the epitope detected is located exclusively on the light (L) beta chain. A strong, but incomplete, association between the beta chain epitope and the expression of the Rg:2 determinant on the alpha chain of the same protein was also observed. While H (heavy) and L beta chains were not associated with a particular C4 isotype, previously unrecorded associations of beta chain polymorphism with the DR locus have been established.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478460     DOI: 10.1007/bf02425274

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  32 in total

1.  'Partial inhibition' of anti-Rg and anti-Ch reagents. II. Demonstration of separable antibodies for different determinants.

Authors:  C M Giles
Journal:  Vox Sang       Date:  1985       Impact factor: 2.144

2.  Localisation of Chido and Rodgers determinants to the C4d fragment of human C4.

Authors:  C A Tilley; D G Romans; M C Crookston
Journal:  Nature       Date:  1978-12-14       Impact factor: 49.962

3.  Genomic hybridization with class II transplantation antigen cDNA probes as a complementary technique in tissue typing.

Authors:  M Andersson; J Böhme; G Andersson; E Möller; E Thorsby; L Rask; P A Peterson
Journal:  Hum Immunol       Date:  1984-10       Impact factor: 2.850

4.  Polymorphic DNA region adjacent to the 5' end of the human insulin gene.

Authors:  G I Bell; J H Karam; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

5.  C4 and HLA haplotypes associated with partial inhibition of anti-Rg and anti-Ch.

Authors:  C M Giles; J R Batchelor; I A Dodi; A H Fielder; C Rittner; G Mauff; K Bender; C Levene; G M Schreuder; L J Wells
Journal:  J Immunogenet       Date:  1984 Oct-Dec

6.  The C4 beta-chain: evidence for a genetically determined polymorphism.

Authors:  G Mauff; M Steuer; M Weck; K Bender
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

7.  Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man.

Authors:  M C Carroll; R D Campbell; R R Porter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

8.  A molecular basis for the two locus model of human complement component C4.

Authors:  M H Roos; E Mollenhauer; P Démant; C Rittner
Journal:  Nature       Date:  1982-08-26       Impact factor: 49.962

9.  An estimate on the frequency of duplicated haplotypes and silent alleles of human C4 protein polymorphism. I. Investigations in healthy Caucasoid families.

Authors:  M Steuer; G Mauff; C Adam; M P Baur; K Bender; J Goetz; S F Goldmann; G Hauptmann; M Neugebauer; M M Tongio
Journal:  Tissue Antigens       Date:  1989-05

Review 10.  Complotypes and extended haplotypes in laboratory medicine.

Authors:  C A Alper; Z L Awdeh; E J Yunis
Journal:  Complement Inflamm       Date:  1989
View more
  3 in total

1.  Immunoblotting human C4 bound to human erythrocytes in vivo and in vitro.

Authors:  C M Giles; T Robson
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

2.  Genetic basis of human complement C4A deficiency. Detection of a point mutation leading to nonexpression.

Authors:  G Barba; C Rittner; P M Schneider
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

3.  Great genotypic and phenotypic diversities associated with copy-number variations of complement C4 and RP-C4-CYP21-TNX (RCCX) modules: a comparison of Asian-Indian and European American populations.

Authors:  Kapil Saxena; Kathryn J Kitzmiller; Yee Ling Wu; Bi Zhou; Nazreen Esack; Leena Hiremath; Erwin K Chung; Yan Yang; C Yung Yu
Journal:  Mol Immunol       Date:  2009-01-09       Impact factor: 4.407

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.